Proscia develops digital pathology software designed to help laboratories and life sciences organizations manage and analyze pathology data.
Proscia has raised $50.0M in total funding. The most recent round was Series D. The last funding was announced in March 2025.
Proscia's investors include Insight Partners, Fusion Fund, Scale Venture Partners, Razor's Edge Ventures, Alpha Intelligence Capital.
Proscia is headquartered in Philadelphia, United States.
Proscia develops digital pathology software designed to help laboratories and life sciences organizations manage and analyze pathology data.
Proscia is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Proscia — Funding & Investors." VCBacked, March 19, 2025, https://www.vcbacked.co/company/proscia. Accessed July 19, 2026.
VCBacked. (2025). Proscia — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/proscia
{{cite web |title=Proscia — Funding & Investors |url=https://www.vcbacked.co/company/proscia |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated